» Articles » PMID: 34585634

MicroRNA-195-3p Inhibits Cyclin Dependent Kinase 1 to Induce Radiosensitivity in Nasopharyngeal Carcinoma

Overview
Journal Bioengineered
Date 2021 Sep 29
PMID 34585634
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are revealed to participate in the progression of multiple malignancies, including nasopharyngeal carcinoma (NPC). This work is intended to decipher the function of microRNA-195-3p (miR-195-3p) in regulating the radiosensitivity of NPC cells and its mechanism. MiR-195-3p and cyclin-dependent kinase 1 (CDK1) expressions were detected in NPC tissues and cells using qRT-PCR and Western blot, respectively. Moreover, radiation-resistant cell lines were induced by continuous irradiation with different doses. Furthermore, the CCK-8 experiment, colony formation assay and flow cytometry were utilized to examine the growth, apoptosis and cell cycle of radioresistant cells. Bioinformatics prediction and dual-luciferase reporter gene assay were applied to prove the targeting relationship between miR-195-3p and CDK1 mRNA 3'UTR. The data showed that miR-195-3p was remarkably down-modulated in NPC tissues and was associated with increased tumor grade, lymph node metastasis and clinical stage of the patients. MiR-195-3p expression was significantly down-modulated in radiation-resistant NPC tissues and NPC cell lines relative to radiation-sensitive NPC tissues and human nasopharyngeal epithelial cells, while CDK1 expression was notably up-modulated. MiR-195-3p overexpression inhibited the growth of NPC cells, decreased radioresistance, promoted apoptosis, and impeded the cell cycle progression. CDK1 was a target gene of miR-195-3p, and CDK1 overexpression counteracted the effects of miR-195-3p on NPC cell growth, apoptosis, cell cycle progression and radiosensitivity. In summary, miR-195-3p improves the radiosensitivity of NPC cells by targeting and regulating CDK1.

Citing Articles

miRNAs in radiotherapy resistance of cancer; a comprehensive review.

Al-Hawary S, Jasim S, Altalbawy F, Kumar A, Kaur H, Pramanik A Cell Biochem Biophys. 2024; 82(3):1665-1679.

PMID: 38805114 DOI: 10.1007/s12013-024-01329-2.


The promising role of miRNAs in radioresistance and chemoresistance of nasopharyngeal carcinoma.

Xu H, Li W, Wang D Front Oncol. 2024; 14:1299249.

PMID: 38482204 PMC: 10933132. DOI: 10.3389/fonc.2024.1299249.


MiRNA signatures in nasopharyngeal carcinoma: molecular mechanisms and therapeutic perspectives.

Chen Y, Lin T, Tang L, He L, He Y Am J Cancer Res. 2024; 13(12):5805-5824.

PMID: 38187072 PMC: 10767356.


MiR-320b aberrant expression enhances the radioresistance of human glioma via upregulated expression of ALDH1A3.

Mao P, Wang T, Gao K, Li Y, Du C, Wang M Aging (Albany NY). 2023; 15(6):2347-2357.

PMID: 36996494 PMC: 10085615. DOI: 10.18632/aging.204617.


Prognostic Value of Serum Transferrin Level before Radiotherapy on Radio-Sensitivity and Survival in Patients with Nasopharyngeal Carcinoma.

Zhan Y, Su L, Lin Q, Pan X, Li X, Zhou W J Pers Med. 2023; 13(3).

PMID: 36983693 PMC: 10055805. DOI: 10.3390/jpm13030511.


References
1.
Izadi S, Nikkhoo A, Hojjat-Farsangi M, Namdar A, Azizi G, Mohammadi H . CDK1 in Breast Cancer: Implications for Theranostic Potential. Anticancer Agents Med Chem. 2020; 20(7):758-767. DOI: 10.2174/1871520620666200203125712. View

2.
Malumbres M, Barbacid M . Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer. 2009; 9(3):153-66. DOI: 10.1038/nrc2602. View

3.
Chen S, Wang L, Yao X, Chen H, Xu C, Tong L . miR-195-5p is critical in REGγ-mediated regulation of wnt/β-catenin pathway in renal cell carcinoma. Oncotarget. 2017; 8(38):63986-64000. PMC: 5609979. DOI: 10.18632/oncotarget.19256. View

4.
Liu H, Chen C, Zeng J, Zhao Z, Hu Q . MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells. PLoS One. 2021; 16(7):e0253522. PMC: 8248614. DOI: 10.1371/journal.pone.0253522. View

5.
Chen J, Gao C, Zhu W . Long non-coding RNA SLC25A25-AS1 exhibits oncogenic roles in non-small cell lung cancer by regulating the microRNA-195-5p/ITGA2 axis. Oncol Lett. 2021; 22(1):529. PMC: 8138898. DOI: 10.3892/ol.2021.12790. View